content top

Short-term Outcomes in Over 500 Intravitreal Bevacizumab Treatments for Retinal or Choroidal Vascular Disease at the New York Eye & Ear Infirmary

http://www.evrs.eu/medias/2006/congress/Short-term-Outcomes-in-Over-500-Intravitreal-Bevacizumab-Treatments-for-Retinal-or-Choroidal-Vascular-Disease-at-the-New-York-Eye-Ear-Infirmary.swf Thomas O. Muldoon, MD (New York, NY), Richard B. Rosen, MD (New York, NY), Sean C. Lalin, MD (New York, NY), Jeanette Dominguez, MD (New York, NY), Ronald C. Gentile, MD(New York, NY) PURPOSE: Assess the short-term outcomes in patients who received...

Read More

Dualing OCT Modalities: Contrasting Retinal Features Revealed by a Dual Mode High Speed Ultrahigh Resolution Spectral and Temporal OCT/SLO Imager

Richard B. Rosen, MD (New York, NY), Patricia Garcia, MD (New York, NY),* Mark Hathaway, PhD (Canterbury, Kent, UK),* Thomas Muldoon, MD (New York, NY), Ronald Gentile, MD (New York, NY), Sean Lalin, MD (New York, NY), Eric Fitz, MD (New York, NY), John Rogers, PhD (Canterbury, Kent, UK),* Justin Pedro, PhD (Toronto, Canada),* Adrian Podoleanu, PhD (Canterbury, UK)* PURPOSE: To describe new aspects of common retinal pathologies revealed by...

Read More
content top